Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel room-temperature method using metal triflates. High yield, recyclable catalyst, green solvents. Ideal for pharma intermediates.
Patent CN109666044B discloses rigid [2.2]paracyclophane ligands enabling efficient asymmetric catalysis with scalable synthesis routes for industrial applications.
Patent CN113789527B reveals a metal-free electrochemical route for aromatic amines, offering green synthesis and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN108299413A enables metal-free synthesis of benzoxazoles. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.
Discover the novel synthesis of Valsartan via Patent CN100522953C. This route eliminates toxic tin azides, ensuring high optical purity and cost-effective manufacturing for global supply chains.
Patent CN112724063A details a high-yield copper-catalyzed route for 3-iodo-4-amino maleimides, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN115448816A reveals a mild, visible-light driven route for beta-fluoroalkenyl alcohols, offering safer manufacturing and cost reduction for pharma intermediates.
Patent CN100383144C reveals a safe, high-yield route for olanzapine intermediates using diester dicarbonates, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel copper-catalyzed carbamate synthesis using CO2 and Togni reagent. Safe, scalable, pharma/agro intermediate production avoiding toxic phosgene.
Patent CN116574039B details a novel cyanation method offering regioselectivity and reduced toxicity for pharmaceutical intermediates. This process enables significant cost reduction and supply chain reliability for global buyers.
Patent CN103012422A details an efficient asymmetric catalysis route for 5,11-methanomorphanthridine compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN110590487A reveals Ru-catalyzed deuteration. Offers high purity and supply chain stability for pharmaceutical intermediates manufacturing and global analysis.
Patent CN102617434B details a novel one-pot method for Vildagliptin. This process reduces purification steps and enhances yield for cost-effective manufacturing.
Patent CN109096329B details a novel asymmetric transfer hydrogenation for chiral beta-hydroxy phosphates, offering cost-effective routes for pharmaceutical intermediates.
Novel one-pot method for econazole nitrate reduces steps and cost. Reliable supply chain for high-purity API manufacturing with enhanced efficiency and green chemistry.
Patent CN103193813B offers high-purity triphenylboron pyridine synthesis. Cost-effective, scalable process for marine coating applications and fungicide manufacturing.